Skip to main content
Funded Studies

Andrew B. Singleton, PhD

Distinguished Investigator at National Institute on Aging

Location: Bethesda, MD United States

Dr. Andrew Singleton is an NIH distinguished investigator and has published more than 500 articles. His laboratory of ~50 staff members includes five principal investigators and three group leaders working on the genetic basis of neurological disorders. The goal of this research is to identify genetic variability that causes or contributes to disease and to use this knowledge to understand the molecular processes underlying disease. Dr. Singleton serves on the scientific advisory board of the Lewy Body Dementia Association and is a member of the editorial boards of nine journals. Dr. Singleton has been awarded the Boehringer Mannheim Research Award, the NIH Director’s Award, the Annemarie Opprecht Award for Parkinson’s Disease Research, the Jay van Andel Award for Outstanding Achievement in Parkinson’s Disease Research, the American Academy of Neurology Movement Disorders Award and an Honorary Doctorate from the University of Sunderland.


Associated Grants

  • Using a Systems-based Approach to Study the Molecular Processes Underlying Parkinson’s Disease: The Foundational Data Initiative

    2022


  • Global Parkinson’s Genetics Program (GP2)

    2019


  • Genome-wide Association Study in Parkinson’s Disease Among an East Asian Population

    2019


  • Mapping Genetic and Molecular Networks Linked to Parkinson’s Disease

    2018


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.